• Some Employers Begin Subsidizing Rather Than Covering GLP-1 Drugs

    Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzWith increasing numbers of employees interested in trying glucagon-like peptide-1 receptor agonist (GLP-1) drugs for weight loss, many employers have found that the high demand has made the cost of insurance coverage for the medications too steep.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; wi

Follow @newsl_pharmacy on Twitter!